**Core Concept**
Cystic fibrosis (CF) is a genetic disorder caused by mutations in the CFTR gene, leading to abnormal chloride transport across epithelial membranes. This results in thick, sticky mucus production in various organs, including the lungs and pancreas. The sweat chloride test is a diagnostic tool to estimate the level of chloride ions in sweat, which can help identify individuals with CF.

**Why the Correct Answer is Right**
The next best test for diagnosing cystic fibrosis, given the intermediate sweat chloride levels of 35 meq/L and 41 meq/L, is a genetic test for the CFTR gene mutation. This is because the sweat chloride test can sometimes produce false negatives, especially in individuals with mild CF or in those with other conditions that can affect sweat chloride levels. A genetic test can directly identify the specific mutation(s) responsible for CF, providing a definitive diagnosis. This is particularly useful in cases where the sweat chloride test results are inconclusive or intermediate.

**Why Each Wrong Option is Incorrect**
**Option A:** The nasal potential difference (NPD) test measures the voltage difference across the nasal epithelium and is used to assess CFTR function. However, it is typically performed in research settings and is not a standard diagnostic tool in clinical practice.

**Option B:** The pancreatic function test (PFT) measures the ability of the pancreas to produce digestive enzymes. While CF can cause pancreatic insufficiency, this test is not the next best step for diagnosing CF, especially in children with intermediate sweat chloride levels.

**Option C:** The immunoreactive trypsinogen (IRT) test measures the level of a pancreatic enzyme in blood and can be used as a screening tool for CF in newborns. However, it is not the next best test for diagnosing CF in a child with intermediate sweat chloride levels.

**Clinical Pearl / High-Yield Fact**
In children with suspected CF, it's essential to remember that intermediate sweat chloride levels (30-59 meq/L) can be seen in up to 10% of the general population and may not necessarily confirm a diagnosis of CF. A genetic test for the CFTR gene mutation is often the next best step in confirming or ruling out CF.

**Correct Answer:** B. Pancreatic function test (PFT)